ArticleScience advances2026

Optimally engineered HLA/peptide-specific CAR-T cells outperform TCR-T cells to eradicate solid tumors.

Corinne E Decker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.